Cadila Pharmaceuticals Limited, founded in 1951 by Shri I.A. Modi, stands as one of the largest privately held pharmaceutical companies in India, based in Ahmedabad, Gujarat. Embracing its slogan, "The Care Continues...", the company excels in developing and manufacturing a diverse range of pharmaceutical products distributed globally to over a hundred countries.
Their strong emphasis on Innovation and Research across more than forty-five therapeutic areas positions them prominently among peers. Major focus areas include cardiovascular, gastrointestinal, and anti-infectives, tapping into high unmet medical needs. A team exceeding 300 scientists bolsters this commitment.
Cadila’s manufacturing prowess is underscored by facilities like the USFDA approved plant in Dholka, Gujarat and a well-regarded site in Samba, Jammu and Kashmir. The international appeal is further enhanced by a thriving base in Addis Ababa, Ethiopia.
Though lacking recent investment momentum, Cadila Pharmaceuticals remains a seasoned player in the Biotechnology and Pharmaceutical sectors, appealing to investors seeking a legacy in healthcare innovation and a broad international footprint.